As of May 27
| -0.05 / -0.79%|
The 3 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 8.00 and a low estimate of 3.00. The median estimate represents a -51.92% decrease from the last price of 6.24.
The current consensus among 3 polled investment analysts is to Buy stock in DelMar Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.